Structural Proteomics: An Opportunity Overview for Investors; Zoom Proteomics System; Applied Biosystems, Millipore, and PerkinElmer have released a joint offering; ProteomIQ | GenomeWeb

The study, “Structural Proteomics: An Opportunity Overview for Investors,” by John Sullivan, is now available through Multex at http://www.multexusa.com/products.asp, for $300. The study provides an overview of the field of structural proteomics, including recent technology developments and an analysis of company valuations. Sullivan is a drug discovery analyst at Stephens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.